355
Views
30
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer’s disease

, , ORCID Icon, , , , & ORCID Icon show all
Pages 3892-3907 | Received 08 Aug 2019, Accepted 03 Sep 2019, Published online: 25 Sep 2019

References

  • Amir, M., Ahmad, S., Ahamad, S., Kumar, V., Mohammad, T., Dohare, R., … Hassan, M. I. (2019). Impact of Gln94Glu mutation on the structure and function of protection of telomere 1, a cause of cutaneous familial melanoma. Journal of Biomolecular Structure and Dynamics, 1–11. doi:10.1080/07391102.2019.1610500
  • Aneja, B., Khan, N. S., Khan, P., Queen, A., Hussain, A., Rehman, M. T., … Abid, M. (2019). Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis. European Journal of Medicinal Chemistry, 163, 840–852. doi:10.1016/j.ejmech.2018.12.026
  • Annadurai, N., Agrawal, K., Dzubak, P., Hajduch, M., & Das, V. (2017). Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease. Cellular and Molecular Life Sciences, 74(22), 4159–4169. doi:10.1007/s00018-017-2574-1
  • Brown, D. K., Penkler, D. L., Sheik Amamuddy, O., Ross, C., Atilgan, A. R., Atilgan, C., & Tastan Bishop, O. (2017). MD-TASK: A software suite for analyzing molecular dynamics trajectories. Bioinformatics, 33(17), 2768–2771. doi:10.1093/bioinformatics/btx349
  • Dahiya, R., Mohammad, T., Roy, S., Anwar, S., Gupta, P., Haque, A., … Hassan, M. I. (2019). Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy. International Journal of Biological Macromolecules, 136, 1076. doi:10.1016/j.ijbiomac.2019.06.158
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. doi:10.1038/srep42717
  • Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. doi:10.1517/17460441.2015.1032936
  • Gu, G. J., Lund, H., Wu, D., Blokzijl, A., Classon, C., von Euler, G., … Kamali-Moghaddam, M. (2013). Role of individual MARK isoforms in phosphorylation of tau at Ser²6² in Alzheimer’s disease. Neuromolecular Medicine, 15(3), 458–469. doi:10.1007/s12017-013-8232-3
  • Harris, T. K., & Mildvan, A. S. (1999). High-precision measurement of hydrogen bond lengths in proteins by nuclear magnetic resonance methods. Proteins: Structure, Function, and Genetics, 35(3), 275–282. doi:10.1002/(SICI)1097-0134(19990515)35:3<275::AID-PROT1>3.0.CO;2-V
  • Homeyer, N., Stoll, F., Hillisch, A., & Gohlke, H. (2014). Binding free energy calculations for lead optimization: Assessment of their accuracy in an industrial drug design context. Journal of Chemical Theory and Computation, 10(8), 3331–3344. doi:10.1021/ct5000296
  • Hopkins, A. L. (2008). Network pharmacology: The next paradigm in drug discovery. Nature Chemical Biology, 4(11), 682. doi:10.1038/nchembio.118
  • Jayapalan, S., Subramanian, D., & Natarajan, J. (2016). Computational identification and analysis of neurodegenerative disease associated protein kinases in hominid genomes. Genes & Diseases, 3(3), 228–237. doi:10.1016/j.gendis.2016.04.004
  • Karplus, M. (2002). Molecular dynamics simulations of biomolecules. Accounts of Chemical Research, 35(6), 321–323.
  • Khan, F. I., Aamir, M., Wei, D.-Q., Ahmad, F., & Hassan, M. I. (2017). Molecular mechanism of Ras-related protein Rab-5A and effect of mutations in the catalytically active phosphate-binding loop. Journal of Biomolecular Structure and Dynamics, 35(1), 105–118. doi:10.1080/07391102.2015.1134346
  • Khan, P., Parkash, A., Islam, A., Ahmad, F., & Hassan, M. I. (2016). Molecular basis of the structural stability of hemochromatosis factor E: A combined molecular dynamic simulation and GdmCl-induced denaturation study. Biopolymers, 105(3), 133–142. doi:10.1002/bip.22760
  • Khan, P., Rahman, S., Queen, A., Manzoor, S., Naz, F., Hasan, G. M., … Hassan, M. I. (2017). Elucidation of dietary polyphenolics as potential inhibitor of microtubule affinity regulating kinase 4: In silico and in vitro studies. Scientific Reports, 7(1), 9470. doi:10.1038/s41598-017-09941-4
  • Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa—A GROMACS tool for high-throughput MM-PBSA calculations . Journal of Chemical Information and Modeling, 54(7), 1951–1962. doi:10.1021/ci500020m
  • Lagunin, A., Filimonov, D., & Poroikov, V. (2010). Multi-targeted natural products evaluation based on biological activity prediction with PASS. Current Pharmaceutical Design, 16(15), 1703–1717. doi:10.2174/138161210791164063
  • Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., … Moore, H. F. (2013). The genotype-tissue expression (GTEx) project. Nature Genetics, 45(6), 580.
  • Lund, H., Gustafsson, E., Svensson, A., Nilsson, M., Berg, M., Sunnemark, D., & von Euler, G. (2014). MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies. Acta Neuropathologica Communications, 2(1), 22. doi:10.1186/2051-5960-2-22
  • Maiorov, V. N., & Crippen, G. M. (1994). Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins. Journal of Molecular Biology, 235(2), 625–634. doi:10.1006/jmbi.1994.1017
  • Mohammad, T., Khan, F. I., Lobb, K. A., Islam, A., Ahmad, F., & Hassan, M. I. (2019). Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4). Journal of Biomolecular Structure and Dynamics, 37(7), 1813–1829. doi:10.1080/07391102.2018.1468282
  • Naiyer, A., Hassan, M. I., Islam, A., Sundd, M., & Ahmad, F. (2015). Structural characterization of MG and pre-MG states of proteins by MD simulations, NMR, and other techniques. Journal of Biomolecular Structure and Dynamics, 33(10), 2267–2284. doi:10.1080/07391102.2014.999354
  • Naz, F., Anjum, F., Islam, A., Ahmad, F., & Hassan, M. I. (2013). Microtubule affinity-regulating kinase 4: Structure, function, and regulation. Cell Biochemistry and Biophysics, 67(2), 485–499. doi:10.1007/s12013-013-9550-7
  • Naz, F., Asad, M., Malhotra, P., Islam, A., Ahmad, F., & Hassan, M. I. (2014). Cloning, expression, purification and refolding of microtubule affinity-regulating kinase 4 expressed in Escherichia coli. Applied Biochemistry and Biotechnology, 172(6), 2838–2848. doi:10.1007/s12010-014-0733-5
  • Naz, F., Islam, A., Ahmad, F., & Hassan, M. I. (2015). Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro. Molecular and Cellular Biochemistry, 410(1-2), 223–228. doi:10.1007/s11010-015-2555-3
  • Naz, F., Khan, F. I., Mohammad, T., Khan, P., Manzoor, S., Hasan, G. M., … Hassan, M. I. (2018). Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. International Journal of Biological Macromolecules, 107, 2580–2589. doi:10.1016/j.ijbiomac.2017.10.143
  • Naz, F., Sami, N., Islam, A., Ahmad, F., & Hassan, M. I. (2016). Ubiquitin-associated domain of MARK4 provides stability at physiological pH. International Journal of Biological Macromolecules, 93, 1147–1154. doi:10.1016/j.ijbiomac.2016.09.087
  • Naz, F., Shahbaaz, M., Bisetty, K., Islam, A., Ahmad, F., & Hassan, M. I. (2015). Designing new kinase inhibitor derivatives as therapeutics against common complex diseases: Structural basis of microtubule affinity-regulating kinase 4 (MARK4) inhibition. Omics: A Journal of Integrative Biology, 19(11), 700–711. doi:10.1089/omi.2015.0111
  • Naz, F., Shahbaaz, M., Khan, S., Bisetty, K., Islam, A., Ahmad, F., & Hassan, M. I. (2015). PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4. Journal of Molecular Graphics and Modelling, 62, 245–252. doi:10.1016/j.jmgm.2015.10.009
  • Parveen, I., Khan, P., Ali, S., Hassan, M. I., & Ahmed, N. (2018). Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors. European Journal of Medicinal Chemistry, 159, 166–177.
  • Rovina, D., Fontana, L., Monti, L., Novielli, C., Panini, N., Sirchia, S. M., … Larizza, L. (2014). Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) plays a role in cell cycle progression and cytoskeletal dynamics. European Journal of Cell Biology, 93(8-9), 355–365. doi:10.1016/j.ejcb.2014.07.004
  • Sack, J. S., Gao, M., Kiefer, S. E., Myers, J. E., Jr., Newitt, J. A., Wu, S., & Yan, C. (2016). Crystal structure of microtubule affinity-regulating kinase 4 catalytic domain in complex with a pyrazolopyrimidine inhibitor. Acta Crystallographica Section F Structural Biology Communications, 72(2), 129–134. doi:10.1107/S2053230X15024747
  • Sami, N., Kumar, V., & Hassan, M. I. (2016). Microtubule Affinity regulating kinase-4. Encyclopedia of Signaling Molecules. New York, NY, Springer New York, pp. 1–16.
  • Schuttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. doi:10.1107/S0907444904011679
  • Seshadri, S., Fitzpatrick, A. L., Ikram, M. A., DeStefano, A. L., Gudnason, V., Boada, M., … Breteler, M. M. B. (2010). Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA, 303(18), 1832–1840. doi:10.1001/jama.2010.574
  • Shahbaaz, M., Amir, M., Rahman, S., Mustafa Hasan, G., Dohare, R., Bisetty, K., … Hassan, M. I. (2018). Structural insights into Rab21 GTPase activation mechanism by molecular dynamics simulations. Molecular Simulation, 44(3), 179–189. doi:10.1080/08927022.2017.1357813
  • Sittel, F., Jain, A., & Stock, G. (2014). Principal component analysis of molecular dynamics: On the use of Cartesian vs. internal coordinates. Journal of Chemical Physics., 141(1), 014111. doi:10.1063/1.4885338
  • Sun, W., Lee, S., Huang, X., Liu, S., Inayathullah, M., Kim, K.-M., … Rajadas, J. (2016). Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer's disease treatment. Scientific Reports, 6, 34784doi:10.1038/srep34784
  • Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014). Protein phosphorylation in neurodegeneration: Friend or foe? Frontiers in Molecular Neuroscience, 7, 42doi:10.3389/fnmol.2014.00042
  • Trinczek, B., Brajenovic, M., Ebneth, A., & Drewes, G. (2004). MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes. Journal of Biological Chemistry, 279(7), 5915–5923. doi:10.1074/jbc.M304528200
  • Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455–461. doi:10.1002/jcc.21334
  • Volkamer, A., Kuhn, D., Rippmann, F., & Rarey, M. (2012). DoGSiteScorer: A web server for automatic binding site prediction, analysis and druggability assessment. Bioinformatics, 28(15), 2074–2075. doi:10.1093/bioinformatics/bts310
  • Voura, M., Khan, P., Thysiadis, S., Katsamakas, S., Queen, A., Hasan, G. M., … Hassan, M. I. (2019). Probing the inhibition of microtubule affinity regulating kinase 4 by N-substituted acridones. Scientific Reports, 9(1), 1676. doi:10.1038/s41598-018-38217-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.